Summit Trail Advisors LLC Raises Holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Summit Trail Advisors LLC increased its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 21.2% in the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 5,934 shares of the company’s stock after acquiring an additional 1,036 shares during the quarter. Summit Trail Advisors LLC’s holdings in GE HealthCare Technologies were worth $464,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Soltis Investment Advisors LLC boosted its position in GE HealthCare Technologies by 21.1% during the fourth quarter. Soltis Investment Advisors LLC now owns 2,656 shares of the company’s stock worth $208,000 after purchasing an additional 462 shares during the period. Savant Capital LLC lifted its stake in shares of GE HealthCare Technologies by 149.7% during the 4th quarter. Savant Capital LLC now owns 27,585 shares of the company’s stock valued at $2,157,000 after buying an additional 16,538 shares in the last quarter. Coronation Fund Managers Ltd. purchased a new stake in shares of GE HealthCare Technologies during the 4th quarter valued at approximately $26,189,000. Tevis Investment Management bought a new position in GE HealthCare Technologies in the 4th quarter worth approximately $1,005,000. Finally, Entropy Technologies LP purchased a new position in GE HealthCare Technologies in the 4th quarter valued at approximately $1,666,000. 82.06% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

GEHC has been the topic of several recent research reports. Jefferies Financial Group upgraded GE HealthCare Technologies from a “hold” rating to a “buy” rating and increased their target price for the stock from $95.00 to $103.00 in a research report on Wednesday, January 8th. Wells Fargo & Company boosted their price objective on GE HealthCare Technologies from $95.00 to $96.00 and gave the company an “overweight” rating in a research note on Thursday, October 31st. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating, nine have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $96.00.

GE HealthCare Technologies Price Performance

Shares of NASDAQ GEHC opened at $87.03 on Wednesday. The firm has a market capitalization of $39.76 billion, a P/E ratio of 23.91, a P/E/G ratio of 2.93 and a beta of 1.15. The company has a quick ratio of 0.98, a current ratio of 1.23 and a debt-to-equity ratio of 1.12. The stock’s 50-day simple moving average is $83.52 and its two-hundred day simple moving average is $85.38. GE HealthCare Technologies Inc. has a twelve month low of $74.51 and a twelve month high of $94.55.

GE HealthCare Technologies Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 14th will be given a $0.035 dividend. This represents a $0.14 annualized dividend and a dividend yield of 0.16%. This is a boost from GE HealthCare Technologies’s previous quarterly dividend of $0.03. The ex-dividend date is Tuesday, January 14th. GE HealthCare Technologies’s dividend payout ratio is 3.85%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.